A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine
Clinical trial NCT04406649 · COMPLETED
Trial details
- NCT number
- NCT04406649
- Sponsor
- Satsuma Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-14
- Primary completion
- 2023-01-16
- Enrollment
- 482
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.